J Moritz Kaths1, Juan Echeverri, Yi Min Chun, Jun Yu Cen, Nicolas Goldaracena, Ivan Linares, Luke S Dingwell, Paul M Yip, Rohan John, Darius Bagli, Istvan Mucsi, Anand Ghanekar, David R Grant, Lisa A Robinson, Markus Selzner. 1. 1 Multi Organ Transplant Program, Department of Surgery, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada. 2 Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada. 3 Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. 4 Department of General, Visceral, and Transplant Surgery, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany. 5 Laboratory Medicine & Pathobiology, Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada. 6 Departments of Surgery (Urology) and Physiology, The Hospital for Sick Children, Toronto, Ontario, Canada. 7 Developmental and Stem Cell Biology, The Hospital for Sick Children, Toronto, Ontario, Canada. 8 Multi Organ Transplant Program, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 9 Transplant and Regenerative Medicine Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Donation after circulatory death (DCD) is current clinical practice to increase the donor pool. Deleterious effects on renal graft function are described for hypothermic preservation. Therefore, current research focuses on investigating alternative preservation techniques, such as normothermic perfusion. METHODS: We compared continuous pressure-controlled normothermic ex vivo kidney perfusion (NEVKP) with static cold storage (SCS) in a porcine model of DCD autotransplantation. After 30 minutes of warm ischemia, right kidneys were removed from 30-kg Yorkshire pigs and preserved with 8-hour NEVKP or in 4°C histidine-tryptophan-ketoglutarate solution (SCS), followed by kidney autotransplantation. RESULTS: Throughout NEVKP, electrolytes and pH values were maintained. Intrarenal resistance decreased over the course of perfusion (0 hour, 1.6 ± 0.51 mm per minute vs 7 hours, 0.34 ± 0.05 mm Hg/mL per minute, P = 0.005). Perfusate lactate concentration also decreased (0 hour, 10.5 ± 0.8 vs 7 hours, 1.4 ± 0.3 mmol/L, P < 0.001). Cellular injury markers lactate dehydrogenase and aspartate aminotransferase were persistently low (lactate dehydrogenase < 100 U/L, below analyzer range; aspartate aminotransferase 0 hour, 15.6 ± 9.3 U/L vs 7 hours, 24.8 ± 14.6 U/L, P = 0.298). After autotransplantation, renal grafts preserved with NEVKP demonstrated lower serum creatinine on days 1 to 7 (P < 0.05) and lower peak values (NEVKP, 5.5 ± 1.7 mg/dL vs SCS, 11.1 ± 2.1 mg/dL, P = 0.002). The creatinine clearance on day 4 was increased in NEVKP-preserved kidneys (NEVKP, 39 ± 6.4 vs SCS, 18 ± 10.6 mL/min; P = 0.012). Serum neutrophil gelatinase-associated lipocalin at day 3 was lower in the NEVKP group (1267 ± 372 vs 2697 ± 1145 ng/mL, P = 0.029). CONCLUSIONS: Continuous pressure-controlled NEVKP improves renal function in DCD kidney transplantation. Normothermic ex vivo kidney perfusion might help to decrease posttransplant delayed graft function rates and to increase the donor pool.
BACKGROUND: Donation after circulatory death (DCD) is current clinical practice to increase the donor pool. Deleterious effects on renal graft function are described for hypothermic preservation. Therefore, current research focuses on investigating alternative preservation techniques, such as normothermic perfusion. METHODS: We compared continuous pressure-controlled normothermic ex vivo kidney perfusion (NEVKP) with static cold storage (SCS) in a porcine model of DCD autotransplantation. After 30 minutes of warm ischemia, right kidneys were removed from 30-kg Yorkshire pigs and preserved with 8-hour NEVKP or in 4°C histidine-tryptophan-ketoglutarate solution (SCS), followed by kidney autotransplantation. RESULTS: Throughout NEVKP, electrolytes and pH values were maintained. Intrarenal resistance decreased over the course of perfusion (0 hour, 1.6 ± 0.51 mm per minute vs 7 hours, 0.34 ± 0.05 mm Hg/mL per minute, P = 0.005). Perfusate lactate concentration also decreased (0 hour, 10.5 ± 0.8 vs 7 hours, 1.4 ± 0.3 mmol/L, P < 0.001). Cellular injury markers lactate dehydrogenase and aspartate aminotransferase were persistently low (lactate dehydrogenase < 100 U/L, below analyzer range; aspartate aminotransferase 0 hour, 15.6 ± 9.3 U/L vs 7 hours, 24.8 ± 14.6 U/L, P = 0.298). After autotransplantation, renal grafts preserved with NEVKP demonstrated lower serum creatinine on days 1 to 7 (P < 0.05) and lower peak values (NEVKP, 5.5 ± 1.7 mg/dL vs SCS, 11.1 ± 2.1 mg/dL, P = 0.002). The creatinine clearance on day 4 was increased in NEVKP-preserved kidneys (NEVKP, 39 ± 6.4 vs SCS, 18 ± 10.6 mL/min; P = 0.012). Serum neutrophil gelatinase-associated lipocalin at day 3 was lower in the NEVKP group (1267 ± 372 vs 2697 ± 1145 ng/mL, P = 0.029). CONCLUSIONS: Continuous pressure-controlled NEVKP improves renal function in DCD kidney transplantation. Normothermic ex vivo kidney perfusion might help to decrease posttransplant delayed graft function rates and to increase the donor pool.
Authors: M O Hamed; Y Chen; L Pasea; C J Watson; N Torpey; J A Bradley; G Pettigrew; K Saeb-Parsy Journal: Am J Transplant Date: 2015-02-23 Impact factor: 8.086
Authors: J Moritz Kaths; Juan Echeverri; Nicolas Goldaracena; Kristine S Louis; Paul Yip; Rohan John; Istvan Mucsi; Anand Ghanekar; Darius Bagli; Markus Selzner; Lisa A Robinson Journal: J Vis Exp Date: 2016-02-21 Impact factor: 1.355
Authors: Matthew F Blum; Qiang Liu; Basem Soliman; Paul Dreher; Toshihiro Okamoto; Emilio D Poggio; David A Goldfarb; William M Baldwin; Cristiano Quintini Journal: J Surg Res Date: 2017-04-20 Impact factor: 2.192
Authors: Peter Urbanellis; Dagmar Kollmann; Ivan Linares; Sujani Ganesh; Fabiola Oquendo; Laura Mazilescu; Toru Goto; Yuki Noguchi; Rohan John; Ana Konvalinka; Istvan Mucsi; Anand Ghanekar; Darius Bagli; Markus Selzner; Lisa A Robinson Journal: Transplant Direct Date: 2020-07-22
Authors: Gregor Fabry; Benedict M Doorschodt; Tim Grzanna; Peter Boor; Aaron Elliott; André Stollenwerk; René H Tolba; Rolf Rossaint; Christian Bleilevens Journal: Sci Rep Date: 2019-09-25 Impact factor: 4.379
Authors: Smriti Juriasingani; Ashley Jackson; Max Yulin Zhang; Aushanth Ruthirakanthan; George J Dugbartey; Emrullah Sogutdelen; Max Levine; Moaath Mandurah; Matthew Whiteman; Patrick Luke; Alp Sener Journal: Int J Mol Sci Date: 2021-07-02 Impact factor: 5.923
Authors: Annemarie Weissenbacher; Letizia Lo Faro; Olga Boubriak; Maria F Soares; Ian S Roberts; James P Hunter; Daniel Voyce; Nikolay Mikov; Andrew Cook; Rutger J Ploeg; Constantin C Coussios; Peter J Friend Journal: Am J Transplant Date: 2018-06-20 Impact factor: 8.086
Authors: Peter Urbanellis; Caitriona M McEvoy; Marko Škrtić; J Moritz Kaths; Dagmar Kollmann; Ivan Linares; Sujani Ganesh; Fabiola Oquendo; Manraj Sharma; Laura Mazilescu; Toru Goto; Yuki Noguchi; Rohan John; Istvan Mucsi; Anand Ghanekar; Darius Bagli; Ana Konvalinka; Markus Selzner; Lisa A Robinson Journal: Transplant Direct Date: 2021-07-08